LivaNova PLC is 1.9x more valuable than Axogen, Inc. by market capitalization ($4.36 B vs $2.29 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AXGN | LIVN |
|---|---|---|
| Market cap | $2.29 B | $4.36 B |
| US-listed rank | #2021 | #1523 |
| Revenue (latest FY) | $225.21M | $1.39B |
| Net income (latest FY) | -$15.70M | -$242.50M |
| Net margin | -7.0% | -17.5% |
| SEC filings | 1,334 | 917 |
LivaNova PLC is 1.9x more valuable than Axogen, Inc. by market capitalization ($4.36 B vs $2.29 B).
In their latest fiscal years, Axogen, Inc. reported $225.21M in revenue while LivaNova PLC reported $1.39B.
Full pages: Axogen, Inc. and LivaNova PLC, or browse the full rankings.